Tavaborole
他伐硼罗
Report date: 2024/04/28 20:00:08
NMEFirst In Class
Base Information
Drug NameTavaborole
Drug Alias Name +[7]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2014/07/07
Country/Territory
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesAnacor Pharmaceuticals Inc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesPfizer IncAnacor Pharmaceuticals Inc
Active IndicationsN/A
Inactive Indications